おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Caribou Biosciences
company
About
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
- 101 - 250
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $150K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Caribou Biosciences is a operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development of therapeutics for agricultural biotechnology, industrial biotechnology and basic and applied biological research.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$115.15M
Caribou Biosciences has raised a total of
$115.15M
in funding over 2 rounds. Their latest funding was raised on
Mar 3, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 3, 2021 | Series C | $115M | 1 | — | — | Detail |
| Jun 21, 2013 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Caribou Biosciences has made 1 investments. Their most recent investment was on
Nov 18, 2014, when Intellia Therapeutics raised $15M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 18, 2014
Intellia Therapeutics
|
Series A | $15M | Biotechnology | — |
Investors
Number of Lead Investors
Number of Investors
1
2
Caribou Biosciences is funded by 2 investors.
National Science Foundation
and Avego Bioscience Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
